1. SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism.
- Author
-
Priam P, Krasteva V, Rousseau P, D'Angelo G, Gaboury L, Sauvageau G, and Lessard JA
- Subjects
- Animals, Animals, Newborn, CCAAT-Enhancer-Binding Proteins metabolism, Chromatin metabolism, Chromatin Assembly and Disassembly, Chromosomal Proteins, Non-Histone genetics, Chromosomal Proteins, Non-Histone metabolism, Gene Expression Regulation, Granulocytes cytology, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Muscle Proteins genetics, Muscle Proteins metabolism, Protein Binding, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factors metabolism, CCAAT-Enhancer-Binding Proteins genetics, Chromatin genetics, Granulocytes metabolism, Hematopoiesis genetics, Mutation, Transcription Factors genetics
- Abstract
Recent studies suggest that individual subunits of chromatin-remodeling complexes produce biologically specific meaning in different cell types through combinatorial assembly. Here we show that granulocyte development requires SMARCD2, a subunit of ATP-dependent SWI/SNF (BAF) chromatin-remodeling complexes. Smarcd2-deficient mice fail to generate functionally mature neutrophils and eosinophils, a phenotype reminiscent of neutrophil-specific granule deficiency (SGD) in humans, for which loss-of-function mutations in CEBPE (encoding CEBPɛ) have been reported. SMARCD2-containing SWI/SNF complexes are necessary for CEBPɛ transcription factor recruitment to the promoter of neutrophilic secondary granule genes and for granulocyte differentiation. The homologous SMARCD1 protein (63% identical at the amino acid level) cannot replace the role of SMARCD2 in granulocyte development. We find that SMARCD2 functional specificity is conferred by its divergent coiled-coil 1 and SWIB domains. Strikingly, both CEBPE and SMARCD2 loss-of-function mutations identified in patients with SGD abolish the interaction with SWI/SNF and thereby secondary granule gene expression, thus providing a molecular basis for this disease.
- Published
- 2017
- Full Text
- View/download PDF